Intraocular iron injection induces oxidative stress followed by elements of geographic atrophy and sympathetic ophthalmia.


Journal

Aging cell
ISSN: 1474-9726
Titre abrégé: Aging Cell
Pays: England
ID NLM: 101130839

Informations de publication

Date de publication:
11 2021
Historique:
revised: 24 08 2021
received: 04 06 2021
accepted: 14 09 2021
pubmed: 10 10 2021
medline: 26 2 2022
entrez: 9 10 2021
Statut: ppublish

Résumé

Iron has been implicated in the pathogenesis of age-related retinal diseases, including age-related macular degeneration (AMD). Previous work showed that intravitreal (IVT) injection of iron induces acute photoreceptor death, lipid peroxidation, and autofluorescence (AF). Herein, we extend this work, finding surprising chronic features of the model: geographic atrophy and sympathetic ophthalmia. We provide new mechanistic insights derived from focal AF in the photoreceptors, quantification of bisretinoids, and localization of carboxyethyl pyrrole, an oxidized adduct of docosahexaenoic acid associated with AMD. In mice given IVT ferric ammonium citrate (FAC), RPE died in patches that slowly expanded at their borders, like human geographic atrophy. There was green AF in the photoreceptor ellipsoid, a mitochondria-rich region, 4 h after injection, followed later by gold AF in rod outer segments, RPE and subretinal myeloid cells. The green AF signature is consistent with flavin adenine dinucleotide, while measured increases in the bisretinoid all-trans-retinal dimer are consistent with the gold AF. FAC induced formation carboxyethyl pyrrole accumulation first in photoreceptors, then in RPE and myeloid cells. Quantitative PCR on neural retina and RPE indicated antioxidant upregulation and inflammation. Unexpectedly, reminiscent of sympathetic ophthalmia, autofluorescent myeloid cells containing abundant iron infiltrated the saline-injected fellow eyes only if the contralateral eye had received IVT FAC. These findings provide mechanistic insights into the potential toxicity caused by AMD-associated retinal iron accumulation. The mouse model will be useful for testing antioxidants, iron chelators, ferroptosis inhibitors, anti-inflammatory medications, and choroidal neovascularization inhibitors.

Identifiants

pubmed: 34626070
doi: 10.1111/acel.13490
pmc: PMC8590099
doi:

Substances chimiques

Ferric Compounds 0
Quaternary Ammonium Compounds 0
Iron E1UOL152H7
ferric ammonium citrate UVP74NG1C5

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13490

Subventions

Organisme : NIH HHS
ID : S10 OD026860
Pays : United States
Organisme : NIH HHS
ID : EY028916
Pays : United States
Organisme : NIH HHS
ID : EY015240
Pays : United States
Organisme : NEI NIH HHS
ID : F30 EY032339
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY019007
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY028916
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY015240
Pays : United States
Organisme : NIH HHS
ID : S10OD026860
Pays : United States
Organisme : NIH HHS
ID : EY028131
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY001583
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY028131
Pays : United States

Informations de copyright

© 2021 The Authors. Aging Cell published by Anatomical Society and John Wiley & Sons Ltd.

Références

Exp Eye Res. 2015 Aug;137:39-49
pubmed: 26026877
Invest Ophthalmol Vis Sci. 1995 Oct;36(11):2327-31
pubmed: 7558729
Aging Cell. 2021 Nov;20(11):e13490
pubmed: 34626070
Graefes Arch Clin Exp Ophthalmol. 1999 Feb;237(2):145-52
pubmed: 9987631
Am J Ophthalmol. 2002 Mar;133(3):341-9
pubmed: 11860971
Cell. 2008 Aug 22;134(4):657-67
pubmed: 18724938
Redox Biol. 2020 Jul;34:101469
pubmed: 32362442
Methods Mol Biol. 2010;652:315-27
pubmed: 20552437
Prog Retin Eye Res. 2012 Mar;31(2):121-35
pubmed: 22209824
Invest Ophthalmol Vis Sci. 1978 Jul;17(7):601-7
pubmed: 669891
Invest Ophthalmol Vis Sci. 2000 Feb;41(2):496-504
pubmed: 10670481
Am J Pathol. 2011 Jul;179(1):335-48
pubmed: 21703414
Curr Eye Res. 1984 Jan;3(1):223-7
pubmed: 6606531
Invest Ophthalmol Vis Sci. 2006 Nov;47(11):4660-4
pubmed: 17065470
Invest Ophthalmol Vis Sci. 2014 Oct 23;55(12):8134-43
pubmed: 25342616
Invest Ophthalmol Vis Sci. 2020 Apr 9;61(4):36
pubmed: 32334431
Prog Retin Eye Res. 2005 Jan;24(1):87-138
pubmed: 15555528
Redox Biol. 2021 Jul;43:101971
pubmed: 33895485
Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2728-36
pubmed: 18326691
Experientia. 1976 May 15;32(5):622-3
pubmed: 1278317
Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5344-52
pubmed: 26275132
Biomark Med. 2010 Apr;4(2):241-63
pubmed: 20406068
FASEB J. 2016 Feb;30(2):813-23
pubmed: 26506980
Trends Cell Biol. 2016 Mar;26(3):165-176
pubmed: 26653790
Invest Ophthalmol Vis Sci. 2007 Jan;48(1):438-45
pubmed: 17197565
Exp Eye Res. 2005 May;80(5):595-606
pubmed: 15862166
Invest Ophthalmol Vis Sci. 1989 Aug;30(8):1691-9
pubmed: 2759786
Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11668-72
pubmed: 15277666
Exp Eye Res. 2016 Oct;151:122-33
pubmed: 27565570
Mol Cell Neurosci. 2011 Mar;46(3):607-13
pubmed: 21211566
Retina. 2007 Oct;27(8):997-1003
pubmed: 18040235
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19273-8
pubmed: 18048333
Invest Ophthalmol Vis Sci. 2014 Jun 26;55(7):4525-32
pubmed: 24970260
Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13850-5
pubmed: 15365174
Invest Ophthalmol Vis Sci. 2011 Jan 05;52(1):109-18
pubmed: 20811044
Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):1063-1075
pubmed: 28192797
Cells. 2020 Mar 13;9(3):
pubmed: 32183063
Arch Ophthalmol. 2003 Aug;121(8):1099-105
pubmed: 12912686
Invest Ophthalmol Vis Sci. 1994 Sep;35(10):3613-24
pubmed: 8088951
Proc Natl Acad Sci U S A. 2018 May 8;115(19):4963-4968
pubmed: 29686088
Am J Pathol. 2012 Apr;180(4):1614-24
pubmed: 22342521

Auteurs

Yingrui Liu (Y)

Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, China.
F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Brent A Bell (BA)

F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Ying Song (Y)

F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Hye J Kim (HJ)

Department of Ophthalmology, Harkness Eye Institute, Columbia University Medical Center, New York, New York, USA.

Jacob K Sterling (JK)

F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Benjamin J Kim (BJ)

Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Maura Poli (M)

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

Michelle Guo (M)

F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Kevin Zhang (K)

F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Aditya Rao (A)

Department of Molecular Life Science, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Janet R Sparrow (JR)

Department of Ophthalmology, Harkness Eye Institute, Columbia University Medical Center, New York, New York, USA.

Guanfang Su (G)

Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, China.

Joshua L Dunaief (JL)

F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH